One entrepreneur was awarded the first Lyfebulb–Novo Nordisk Innovation Award, sponsored by Novo Nordisk.
WHY PATIENT ENTREPRENEURS MATTER?
Patient entrepreneurs have a unique ability to create a value-adding disease intervention beyond therapy. Our aim is to support patient-driven innovation and laser-focus on improving the quality of life for those living with diabetes.
At this Summit, 10 selected patient entrepreneurs were given an opportunity to engage with Lyfebulb founders and Novo Nordisk Device R&D researchers and engineers
ABOUT THE SUMMIT
6-7 DECEMBER 2016 AT NOVO NORDISK HQ COPENHAGEN, DENMARK
The Lyfebulb–Novo Nordisk Innovation Summit was built on the idea of the Lyfebulb Entrepreneur Circle, which was established in 2015, and features people who either have diabetes or have a close relative with the disease, and have created a product and/or a company based on issues encountered because of their personal experiences with diabetes.
At this Summit, the top 10 patient entrepreneur finalists were given an opportunity to engage with scientists and engineers within the Novo Nordisk Device R&D teams, as well as with the Lyfebulb founders. Beyond presenting their innovative ventures to this group, the 10 finalists also had a chance to interact and exchange ideas on how to advance further patient entrepreneurship in the diabetes community.
BENEFITS OF THE LYFEBULB–NOVO NORDISK INNOVATION AWARD
National and international recognition. The benefit for patient entrepreneurs of participating is the visibility given to the selected 10 finalists and the Winner in particular.
Invitation to the Lyfebulb–Novo Nordisk Innovation Summit 2016 in Copenhagen as one of 10 Finalists. The Innovation Summit aims to link entrepreneurs with senior device researchers and engineers from Novo Nordisk in order to spotlight entrepreneurs’ efforts and ideas, and provide professional discussion, direction, and inspiration. During the day, in mixed teams of Novo Nordisk engineers and entrepreneurs, the group was presented an innovation challenge. Teams were tasked to develop ideas together through brainstorming and prototyping.
The winner was announced on 7 December during the annual Patient Disease expert meeting. The winner was chosen, by a judging panel made up of international representatives of the diabetes patient community.